Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Long-Term Investments (2018 - 2024)

Cryo Cell International's Long-Term Investments history spans 13 years, with the latest figure at $308000.0 for Q1 2024.

  • Quarterly results put Long-Term Investments at $308000.0 for Q1 2024, changed 0.0% from a year ago — trailing twelve months through Feb 2024 was $308000.0 (changed 0.0% YoY), and the annual figure for FY2023 was $308000.0, changed 0.0%.
  • Long-Term Investments for Q1 2024 was $308000.0 at Cryo Cell International, roughly flat from $308000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $350000.0 in Q3 2020 to a low of $308000.0 in Q1 2020.
  • The 5-year median for Long-Term Investments is $308000.0 (2020), against an average of $312941.2.
  • The sharpest move saw Long-Term Investments rose 13.64% in 2020, then dropped 12.0% in 2021.
  • Year by year, Long-Term Investments stood at $350000.0 in 2020, then dropped by 12.0% to $308000.0 in 2021, then changed by 0.0% to $308000.0 in 2022, then changed by 0.0% to $308000.0 in 2023, then changed by 0.0% to $308000.0 in 2024.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $308000.0, $308000.0, and $308000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.